肝移植受者术前预康复的研究进展

doi:10.16460/j.issn1008-9969.2022.15.039

摘要/Abstract

摘要： 目的对肝移植受者术前预康复内容进行综述,为开展肝移植受者术前预康复研究提供参考。方法相关文献并进行梳理,从预康复概念、肝移植受者进行术前预康复的原因、肝移植受者术前预康复内容进行综述。结果肌肉减少症、营养不良、衰弱是肝移植受者术前常见的症状,均与移植前死亡率密切相关,可通过术前预康复措施预防或改善。肝移植受者术前预康复措施主要包括：运动干预、营养干预及心理干预3方面,术前进行每周3次（每次40~70 min）中等强度的有氧训练联合抗阻运动,同时给予营养支持确保达到能量摄入30~35 kCal/kg·d及蛋白质1.2~1.5 g/kg·d,并且进行多学科协作的心理社会支持。结论肝移植受者术前预康复措施可改善肝移植受者的机体功能,提高生活质量。目前,国内无相应的规范,有待通过循证研究制定适合肝移植受者的术前预康复措施,并应用于临床。

中图分类号:

R493

孙慧慧, 孙菊, 程莉洁, 徐晓玮, 张胜龙, 张丙良. 肝移植受者术前预康复的研究进展[J]. 护理学报, 2022, 29(15): 39-43.

参考文献

[1] Román E, Torrades MT, Nadal MJ, et al.Randomized Pilot Study: Effects of an Exercise Programme and Leucine Supplementation in Patients with Cirrhosis[J]. Digestive Diseases Sciences, 2014,59(8):1966-1975.DOI:10.1007/s10620-014-3086-6.
[2] Ponziani FR, Gasbarrini A, et al.Sarcopenia in Patients with Advanced Liver Disease[J]. Current Protein and Peptide Science,2018,19(7):681-691.DOI:10.2174/1389203718666170428121647.
[3] Vugt J, Levolger S, Bruin R, et al.Systematic Review and Meta-analysis of the Impact of Computed Tomography-assessed Skeletal Muscle Mass on Outcome in Patients Awaiting or Undergoing Liver Transplantation[J]. Am J Transplant, 2016,16(8).DOI:10.1111/ajt.13732.
[4] 国家卫生计生委医管中心加速康复外科专家委员会.中国肝移植围手术期加速康复管理专家共识(2018版)[J]. 中华普通外科杂志, 2018,33(3):268-272.DOI:10.3760/cma.j.issn.1007-631X.2018.03.030.
[5] McIsaac DI, Gill M, Boland L, et al. Prehabilitation in Adult Patients Undergoing Surgery: An Umbrella Review of Systematic Reviews[J]. Br J Anaesth, 2021,128(2):244-257.DOI:10.1016/j.bja.2021.11.014
[6] Scheede-Bergdahl C,Minnella EM, Carli F, et al.Multi-modal Prehabilitation: Addressing the Why, When, What, How, Who and Where Next?[J]. Anaesthesia, 2019,74(1):20-26.DOI:10.1111/anae.14505 .
[7] 戴秀娟, 吴茜. 三联预康复在胃肠肿瘤外科中应用的研究进展[J]. 中国实用护理杂志, 2021,37(4):317-321.DOI:10.3760/cma.j.cn211501-20200426-02055.
[8] Tandon P, Ney M, Irwin I, et al.Severe Muscle Depletion in Patients on the Liver Transplant Wait List: Its Prevalence and Independent Prognostic Value[J]. Liver Transplant, 2012,18(10):1209-1216.DOI:10.1002/lt.23495 .
[9] Ebadi M, Montano-loza AJ. Sarcopenia and Frailty in the Prognosis of Patients on the Liver Transplant Waiting List[J]. Liver Transpl,2019,25(1):7-9.DOI:10.1002/lt.25386.
[10] Tandon P, Tangri N, Thomas L, et al.A Rapid Bedside Screen to Predict Unplanned Hospitalization and Death in Outpatients with Cirrhosis: A Prospective Evaluation of the Clinical Frailty Scale[J]. J Hepatol,2016,64(2):S282-S283.DOI:10.1016/S0168-8278(16)00341-X.
[11] Brustia R, Savier E, Scatton O, et al.Physical Exercise in Cirrhotic Patients: Towards Prehabilitation on Waiting List for Liver Transplantation.A Systematic Review and Meta-Analysis[J]. Clin Res Hepatol Gastroenterol, 2018,42(3):205-215.DOI:10.1016/j.clinre.2017.09.005 .
[12] Sinclair M, Gow PJ, Grossmann M, et al.Review Article: Sarcopenia in Cirrhosis-aetiology, Implications and Potential Therapeutic Interventions[J].Aliment Pharmacol Therap, 2016,43(7):765-777.DOI:10.1111/apt.13549 .
[13] Dimartini A, Cruz Jr RJ, Dew MA,et al.Muscle Mass Predicts Outcomes Following Liver Transplantation[J]. Liver Transplant, 2013(19):1172-1180.DOI:10.1002/lt.23724.
[14] 王森岩, 丁蕾蕾, 刘龙, 等. 肝移植受者的营养评价与管理[J]. 实用器官移植电子杂志, 2019,7(6):437-441.
[15] Kalafateli M, Mantzoukis K, Choi YY, et al. Malnutrition and Sarcopenia Predict Post-liver Transplantation Outcomes Independently of the Model for End-stage Liver Disease Score[J]. J Cachexia Sarcopenia Muscle, 2017,8(1):113-121.10.1002/jcsm.12095.DOI:10.1002/jcsm.12095.
[16] Gunsar F, Raimondo ML, Jones S, et al. Nutritional Status and Prognosis in Cirrhotic Patients[J]. Aliment Pharmacol Ther, 2006,24(4):563-572.DOI10.1111/j.1365-2036.2006.03003.x.
[17] Lai JC, Sonnenday CJ, Tapper EB, et al.Frailty in Liver Transplantation:An Expert Opinion Statement from the American Society of Transplantation Liver and Intestinal Community of Practice[J]. Am J Transplant, 2019,19(7):1896-1906.DOI:10.1111/ajt.15392 .
[18] Cron DC, Friedman JF, Winder GS, et al.Depression and Frailty in Patients with End-stage Liver Disease Referred for Transplant Evaluation[J]. Am J Transplant, 2016,16(6):1805-1811.DOI:10.1111/ajt.13639.
[19] Lai JC, Feng S, Terrault NA, et al.Frailty Predicts Waitlist Mortality in Liver Transplant Candidates[J].Am J Transplant, 2014,14(8):1870-1879.DOI:10.1111/ajt.12762.
[20] Sinclair M, Poltavskiy E, Dodge JL, et al.Frailty Is Independently Associated with Increased Hospitalisation Days in Patients on the Liver Transplant Waitlist[J]. World J Gastroenterol, 2017(5):899.DOI:10.3748/wjg.v23.i5.899.
[21] Román E, Torrades MT, Nadal MJ, et al.Randomized Pilot Study: Effects of an Exercise Programme and Leucine Supplementation in Patients with Cirrhosis[J]. Digest Dis Sci, 2014, 59(8):1966-1975.DOI:10.1007/s10620-014-3086-6.
[22] Duarte-Rojo A, Ruiz-Margáin A, Monta O-Loza AJ, et al. Exercise and Physical Activity for Patients with Esld: Improving Functional Status and Sarcopenia While on the Transplant Waitlist[J]. Liver Transplant, 2018,24(1):122-139.DOI:10.1002/lt.24958.
[23] Eva R, Cristina GG, Teresa T, et al.Effects of an Exercise Programme on Functional Capacity, Body Composition and Risk of Falls in Patients with Cirrhosis: A Randomized Clinical Trial[J]. Plos One, 2016,11(3):e151652.DOI:10.1371/journal.pone.0151652.
[24] Williams FR, Vallance A, Faulkner T, et al.Home-based Exercise Therapy in Patients Awaiting Liver Transplantation: Protocol for an Observational Feasibility Trial[J]. BMJ Open, 2018, 8(1):e19298. DOI:10.1136/bmjopen-2017-019298.
[25] Berzigotti A, Albillos A, Villanueva C, et al.Effects of An Intensive Lifestyle Intervention Program on Portal Hypertension in Patients with Cirrhosis and Obesity: The Sport Diet Study[J]. Hepatology, 2017,65(4):1293-1305.DOI:10.1002/hep.28992.
[26] Morkane CM, Kearney O, Bruce DA, et al.An Outpatient Hospital-based Exercise Training Program for Patients with Cirrhotic Liver Disease Awaiting Transplantation: A Feasibility Trial[J]. Transplant J, 2020:97-103.DOI:10.1097/TP.0000000000002803.
[27] Wallen MP, Keating SE, Hall A, et al.Exercise Training Is Safe and Feasible in Patients Awaiting Liver Transplantation: A Pilot Randomized Controlled Trial[J]. Liver Transplant, 2019,25(10).DOI:10.1002/lt.25616.
[28] Hammad A, Kaido T, Aliyev V, et al.Nutritional Therapy in Liver Transplantation[J]. Nutrients, 2002,9(10):114-122.DOI:10.1590/s0004-28032002000200009.
[29] 中华医学会器官移植学分会围手术期管理学组. 肝移植围手术期营养支持专家共识(2021版)[J]. 中华器官移植杂志,2021,42(7):7.DOI:10.3760/cma.j.cn421203-20210219-00063.
[30] 段钟平, 杨云生. 终末期肝病临床营养指南[J]. 实用肝脏病杂志, 2019,22(5):624-635.
[31] Stephenson GR, Moretti EW, Elmoalem H, et al.Malnutrition in Liver Transplant Patients: Preoperative Subjective Global Assessment Is Predictive of Outcome after Liver Transplantation[J]. Transplant, 2001,72(4):666-670.DOI:10.1097/00007890-200108270-00018.
[32] Mullen JL, Buzby GP, Waldman MT, et al.Prediction of Operative Morbidity and Mortality by Preoperative Nutritional Assessment[J]. Surgical Forum, 1979,30(30):80-82.
[33] Riordan SM, Williams R.Nutrition and Liver Transplantation[J].J Hepatol,1999,31(5):955-962. DOI:10.1016/S0168-8278(99)80300-6.
[34] Bischoff SC, Bernal W, Dasarathy S, et al.ESPEN Practical Guideline: Clinical Nutrition in Liver Disease[J]. Clin Nutr, 2020, 39(12):3533-3562.DOI:10.1016/j.clnu.2020.09.001.
[35] Sugihara K, Yamanaka-Okumura H, Teramoto A, et al.Recovery of Nutritional Metabolism after Liver Transplantation[J]. Nutr,2014,31(1):105-110.DOI:10.1016/j.nut.2014.05.016.
[36] Kaido T, Ogawa K, Fujimoto Y, et al.Impact of Sarcopenia on Survival in Patients Undergoing Living Donor Liver Transplantation[J]. Am J Transplant, 2013,13(6):1549-1556.DOI:10.1111/ajt.12221.
[37] Kaido T, Mori A, Ogura Y, et al.Impact of Enteral Nutrition Using a New Immuno-modulating Diet after Liver Transplantation[J]. Hepato-gastroenterol, 2010,57(104):1522-1525.
[38] Bischoff SC, Bernal W, Dasarathy S, et al.ESPEN Practical Guideline: Clinical Nutrition in Liver Disease[J]. Clin Nutr, 2020, 39(12):3533-3562.DOI:10.1016/j.clnu.2020.09.001.
[39] Ofliver E.EASL Clinical Practice Guidelines on Nutrition in Chronic Liver Disease[J]. J Hepatol, 2019,70(1):172-193.DOI:10.1016/j.jhep.2018.06.024.
[40] Bitetto D, Fabris C, Falleti E, et al.Vitamin D and the Risk of Acute Allograft Rejection Following Human Liver Transplantation[J]. Liver Int, 2010(30):417-444.DOI:10.1111/j.1478-3231.2009.02154.x.
[41] Tsuchiya M, Sakaida I, Okamoto M, et al.The Effect of a Late Evening Snack in Patients with Liver Cirrhosis[J]. Hepatol Res,2005, 31(2):95-103.DOI:10.1016/j.hepres.2004.11.009.
[42] Sugawara G, Nagino M, Nishio H,et al.Perioperative Synbiotic Treatment to Prevent Postoperative Infectious Complications in Biliary Cancer Surgery: A Randomized Controlled Trial[J]. Annals Surg, 2006,244(5):706-714.DOI:10.1097/01.sla.0000219039.20924.88.
[43] Fineberg SK, West A, Na PJ, et al.Utility of Pretransplant Psychological Measures to Predict Posttransplant Outcomes in Liver Transplant Patients: A Systematic Review[J]. General Hospital Psychiatry, 2016, 40(1):4-11. DOI:10.1016/j.genhosppsych.2016.01.006.
[44] Eftekar M, Pun P.Psychiatric Risk Factors Predicting Post-liver Transplant Physical and Psychiatric Complications: A Literature Review[J]. Australasian Psychiatry, 2016:1683592840.DOI:10.1177/1039856215627400.
[45] Santos GGD, Gon Alves LCS, Buzzo N, et al.Quality of Life, Depression, and Psychosocial Characteristics of Patients Awaiting Liver Transplants[J].Transplant Proc, 2012,44(8):2413-2415.DOI:10.1016/j.transproceed.2012.07.046.
[46] Golfieri L, Gitto S, Vukotic R, et al.Impact of Psychosocial Status on Liver Transplant Process[J]. Annals Hepatol,2019,18(6):804-809.DOI:10.1016/j.aohep.2019.06.011.
[47] Telles-Correia D, Barbosa A, Mega I, et al.Psychiatric and Psychosocial Predictors of Medical Outcome after Liver Transplantation: A Prospective, Single-center Study[J]. Transplantation Proceedings, 2011,43(1):155-157.DOI:10.1016/j.transproceed.2010.12.006 .
[48] Ordin YS, Karayurt Z.Effects of a Support Group Intervention on Physical, Psychological, and Social Adaptation of Liver Transplant Recipients[J]. Experimental and Clinical Transplantation,2015, 14(3):329-337.DOI:10.6002/ect.2014.0220.
[49] 刘妍, 王靖. 整合式心理护理在肝移植患者中的应用效果[J]. 世界华人消化杂志, 2015,23(5):804-808.
[50] Locklear CT, Golabi P, Gerber L, et al.Exercise as an Intervention for Patients with End-stage Liver Disease Systematic Review[J]. 2019(97):42.DOI:10.1097/MD.0000000000012774.
[51] Zenith L, Meena N, Ramadi A, et al.Eight Weeks of Exercise Training Increases Aerobic Capacity and Muscle Mass and Reduces Fatigue in Patients with Cirrhosis[J]. Clin Gastroenterol Hepatol, 2014, 12(11):1213-1920.DOI:10.1016/j.cgh.2014.04.016.
[52] Cornu K, Mckiernan FJ, Kapadia SA, et al.A Prospective Randomized Study of Preoperative Nutritional Supplementation in Patients Awaiting Elective Orthotopic Liver Transplantation1[J]. Transplantation, 2000,69(7):1364-1369.
[53] De Be Tte-Gratien M, Tabouret T, Antonini MT, et al. Personalized Adapted Physical Activity before Liver Transplantation: Acceptability and Results[J]. Transplantation, 2015,99(1):145.DOI:10.1097/tp.0000000000000245.
[54] Pattullo V, Duarte-Rojo A, Soliman W, et al.A 24-week Dietary and Physical Activity Lifestyle Intervention Reduces Hepatic Insulin Resistance in the Obese with Chronic Hepatitis C[J]. Liver Int, 2012.DOI:10.1111/liv.12041.

Metrics

Viewed

Full text

Abstract

Cited

Shared